Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

274
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
274
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

245
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
245

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-Point versus Multi-Point Mechanical Loading in Membrane Deformation: Insights from Molecular Dynamics Simulations.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

A Radial-Linear π-Conjugated Polymer by Integrating Poly(Para-phenylene Vinylene) and Cycloparaphenylene for Enhanced Optoelectronic and Electrochemical Performance.

Angewandte Chemie (International ed. in English)·2026
Same author

Correction to "Polycation-Carbon Nanohybrids with Superior Rough Hollow Morphology for the NIR-II Responsive Multimodal Therapy".

ACS applied materials & interfaces·2026
Same author

The perioperative effect of ERAS protocol in patients with lung cancer: a randomized controlled study.

Journal of cardiothoracic surgery·2026
Same author

A multimodal deep learning model predicting hyperprogressive disease for PD-1 blockade in advanced hepatocellular carcinoma.

NPJ digital medicine·2026
Same author

Reduced C3 Levels Link Dyslipidemia and Renal Involvement in Systemic Lupus Erythematosus.

Journal of inflammation research·2026

Related Experiment Video

Updated: Oct 12, 2025

Vessel-sparing Excision and Primary Anastomosis
08:09

Vessel-sparing Excision and Primary Anastomosis

Published on: January 7, 2019

11.6K

Prostatic artery embolization: Progress and prospect.

Li Cui1, Yanhua Bai1, Jinlong Zhang1

  • 1Department of Interventional Radiology, The General Hospital of Chinese People's Liberation Army, Beijing, 100853, China.

Journal of Interventional Medicine
|November 22, 2021
PubMed
Summary
This summary is machine-generated.

Prostate artery embolization (PAE) offers a promising minimally invasive treatment for benign prostatic hyperplasia (BPH). This review covers recent studies on PAE, discussing its benefits and drawbacks for BPH management.

Keywords:
BPHBenign prostatic hyperplasiaPAEProstatic artery embolization

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.1K
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

8.1K

Related Experiment Videos

Last Updated: Oct 12, 2025

Vessel-sparing Excision and Primary Anastomosis
08:09

Vessel-sparing Excision and Primary Anastomosis

Published on: January 7, 2019

11.6K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.1K
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

8.1K

Area of Science:

  • Urology
  • Interventional Radiology

Background:

  • Benign prostatic hyperplasia (BPH) is a common condition in aging men.
  • Current treatments for BPH have limitations and side effects.
  • Prostate artery embolization (PAE) has emerged as a novel therapeutic option.

Purpose of the Study:

  • To provide an up-to-date review of prostate artery embolization (PAE).
  • To evaluate the efficacy and safety of PAE for treating benign prostatic hyperplasia (BPH).
  • To discuss the advantages and disadvantages of PAE.

Main Methods:

  • Comprehensive literature search of retrospective studies and randomized controlled trials.
  • Analysis of data on patient outcomes, technical success, and complications.
  • Review of current evidence on PAE for BPH.

Main Results:

  • PAE demonstrates significant symptom improvement in patients with BPH.
  • PAE is associated with a favorable safety profile and low complication rates.
  • Comparison with traditional BPH treatments highlights PAE's minimally invasive nature.

Conclusions:

  • Prostate artery embolization is a safe and effective minimally invasive treatment for BPH.
  • PAE offers a valuable alternative for patients seeking relief from BPH symptoms.
  • Further research and standardization of PAE techniques are ongoing.